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Abstract 
Nucleotide sequences containing CpG-motifs are recognized as 
immunomodulators in pigs among other species. Phosphodiester 
oligodeoxynucleotides (ODNs), such as ODN H, have been 
demonstrated to be potent inducers of interferon-alpha (INF-α) in 
porcine blood mononuclear cells (poPBMC) provided they are pre-
treated with Lipofectin®. In the present study the IFN-α inducing 
activity of ODN H was demonstrated to be altered after addition of 
poly-G sequences at the 5’ and/or 3’ end and by increasing the number 
of nucleotides (nt) in the base-pairing sequence of the ODN. 
Alterations that facilitated the formation of secondary structures 
reduced the need for pre-treatment with Lipofectin®. Furthermore, 
deliberate destruction of secondary structures by heat-treatment of 
ODN 2216 reduced the IFN-α inducing capacity of that ODN. Thus, 
results suggest that the stimulatory activity of the ODNs is dependent 
on secondary structure formation. Other ODNs are recognized as potent 
inhibitors of the INF-α production in poPBMC. The ODN PCV2/1 
corresponding to a 20 nt long sequence from the genome of PCV2, has 
been identified as such an inhibitory ODN. Further, it was 
demonstrated that the inhibitory capacity of ODN PCV2/1 not depend 
on the presence of a central CpG-motif. Further, results from the in 
vitro studies show a significant difference between ODN PCV2/1 found 
in the genome of PCV2 from healthy pigs in Sweden and ODN 
PCV2/1S1, which predominates in pigs from farms with PMWS in 
Sweden. However, the biological significance of these findings remain 
to be elucidated. 
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Sammanfattning 
Nukleotidsekvenser i mikrobiellt DNA som innehåller CpG-motiv kan 
fungera som immumodulatorer hos bl.a. gris. För att efterlikna detta in 
vitro kan man använda sig av oligodeoxynukleotider (ODN). Vissa 
fosfodiester ODN, såsom ODN H, har visat sig kunna aktivera vita 
blodkroppar så att de producerar interferon-alfa (IFN-α) förutsatt att 
oligodeoxynukleotiderna förbehandlats med Lipofektin®. Denna studie 
visar att den IFN-α inducerande förmågan hos ODN H kan förändras 
genom tillsats av poly-G sekvenser till 5’ och/eller 3’ änden samt 
genom en ökning av antalet nukleotider i den basparande sträckan. För 
att undersöka hur den stimulatoriska aktiviteten påverkas av 
denaturering utfördes studier på ODN 2216, som har förmågan att 
baspara med sig själv. Resultaten visade på en minskning av den IFN-α 
inducerande aktiviteten efter denaturering vilket tyder på att den 
stimulatoriska aktiviteten hos en ODN är beroende av formation av 
sekundärstrukturer. Andra ODN har visat sig kunna inhiberar IFN-α 
produktionen från vita blodkroppar, till dessa hör ODN PCV2/1 som 
motsvarar en 20 nt lång sekvens som återfinns i genomet hos porcint 
circovirus typ 2 (PCV2) hos friska grisar i Sverige. In vitro studien 
visar att det centrala CpG-motivet inte är nödvändigt för den 
inhiberande förmågan hos ODN PCV2/1. Studien visar dock på en 
signifikant skillnad mellan den IFN-α inhiberande kapaciten hos ODN 
PCV2/1 och ODN PCV2/1S1, som dominerar bland grisar från svenska 
besättningar med PMWS och saknar det centrala CpG-motivet. Det 
kvarstår dock att klarlägga den bilogiska relevansen av dessa fynd.  
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Introduction 
Porcine circoviruses (PCV) are small, nonenveloped viruses (Allan et 
al., 2000) that were first identified as a contaminant of the continuous 
pig kidney cell line PK/15 in 1974 (Tischer et al., 1974). The virus 
(PCV PK/15) was shown to have a single-stranded, circular DNA 
genome of 1.76 kb and was classified into the animal virus family, 
Circoviridae. The viron DNA has four conserved open reading frames 
(ORFs) and is encapsulated by a single viral protein, coded for by ORF 
2 (Meehan et al., 1998; Mankertz et al., 2004). 
 
Today two genotypes of PCV have been isolated from pigs, PCV1 that 
corresponds to the circovirus first described in PK15 cells (Tischer et 
al., 1974), and PCV2 (Meehan et al., 1998). Isolates of PCV2 are 
highly homologous (> 96%) while the homology between PCV1 and 
PCV2 isolates is roughly 62% (Allan et al., 1999b). PCV1 does not 
produce clinical disease at experimental infection in pigs and is 
considered apathogenic (Krakowka et al., 2000). PCV2 on the other 
hand is now recognised as a porcine pathogen and is generally accepted 
as the causal agent of postweaning multisystemic wasting syndrome 
(PMWS). The clinical signs of PMWS include wasting or unthriftiness, 
enlarged lymph nodes, dyspnea, diarrhea and pallor or icterus (Ellis et 
al., 1998). At necropsy, lesions in liver, kidneys and lymph nodes are 
common findings and a criteria for the diagnose PMWS is that PCV2 is 
demonstrated in the leisons (Allan et al., 1998; Ellis et al., 1998; 
Kennedy et al., 2000; Krakowka et al., 2000, 2001). 
 
Although PCV2 is the infectious agent that always is present at PMWS, 
also other factors i.e. other infectious agents or nonspecific immune 
modulators appear to be essential for full development of clinical 
disease (Allan et al., 1999a; Kennedy et al., 2000; Krakowka et al., 
2001). PMWS was first recognised in a Canadian herd in 1991 and has 
since then been described in several countries within and outside 
Europe. PMWS was reported for the first time in Sweden in December 
2003 and is now spreading rather slowly through Swedish pig herds. A 
pilot study in Sweden has shown that 96% of randomly selected 
porcine sera contained antibodies to PCV2 (Linné et al., 2000), which 
confirms that the virus infection is widespread among Swedish pigs. 
PCV2 has also been associated with several other severe diseases in 
pigs such as porcine dermatitis and nephropathy syndrome (PDNS) 
(Allan et al., 2000) and during the last years four cases of PDNS have 
occurred in Sweden.  
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The majority of pigs are however persistently infected with PCV2 
without showing any signs of clinical disease, and in vitro studies have 
identified cells of the monocyte/macrophage lineage, including 
dendritic cells, as the primary targets for PCV2 infection (Gilpin et al., 
2003; Vincent et al., 2003). Although large amounts of infectious virus 
can accumulate in these cells the virus does not seem to be replicating 
(Gilpin et al., 2003). The fact that PCV2 lacks its own DNA 
polymerase forces the virus to depend on the host cell for its 
replication. Thus, cells that regularly undergo division and therefore 
have an active polymerase are most likely to be favourable for 
replication of the virus. Nevertheless, monocytes/macrophages and 
histiocytes, sometimes in the form of multinucleated giant cells, are the 
predominant cell types that accumulate in the lymph nodes when these 
become depleted of lymphocytes at the late stages of PMWS (Rosell et 
al., 1999, Segalés et al., 2004). It is therefore intriguing to speculate 
that PCV2 in one way or another modulates the normal activity of the 
cells that harbours the virus. In that context it is notable that PCV2 
antigen also seems to be acquired by the subpopulation of dendritic 
cells, referred to as natural interferon producing cells.  
 
Natural interferon producing cells (NIPCs) represent 0.2%-0.8% of 
peripheral blood mononuclear cells in human and mice. These cells are 
specialised in rapid (within 24 h) secretion of massive amounts of type 
I IFNs (IFN-α and -β) following a viral infection. NIPC produce 100-
1000 times more type I IFN than for instance monocytes/macrophages 
following exposure to Herpes simplex virus (Liu, 2005). A 
corresponding celltype that respond with IFN-α production at exposure 
to a porcine herpes virus, Aujeszky’s Disease Virus (ADV) has been 
identified in the pig (Artursson et al., 1995). This porcine NIPC 
constitute approximately 0.3% of poPBMC and as its human 
counterpart it also responds with IFN-α production at exposure to DNA 
containing immunostimulating sequences (Domeika et al., 2004, 
Guzylack-Piriou et al., 2004) The immunostimulatory effect of e.g. 
bacterial DNA is ascribed to the relatively high content of 
unmethylated CpG dinucelotides in certain base contexts (Sato et al., 
1996; Krieg, 2002). To characterise immunostimulatory DNA motifs 
(IS-DNA), plasmid DNA (Nelson et al., 1999; for review see Pisetsky, 
1996) or synthetic oligodeoxynucleotides (ODNs) have been 
extensively used (for review see Agrawal et al., 2002). 
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Plasmid DNA and ODN 2216 are both believed to interact via their 
CpG motifs with Toll-like receptor 9 (TLR 9). This interaction results 
in an induction of cytokine production, proliferation and/or 
immunoglobulin secretion and an enhanced NK-cell activity (Sato et 
al., 1996; Krieg, 2002). The importance of TLR 9 for CpG DNA-
mediated effects is supported by studies on TLR 9-deficient (TLR9-/-) 
mice, that are resistant to the lethal effect of DNA containing 
unmethylated CpG dinucleotides (Hemmi et al., 2000). It has also been 
suggested that both stimulatory and inhibitory CpG-motifs exist and act 
on the same cells (Yamada et al., 2002). Analysis of the PCV2 genome 
in search for potentially immunoregulatory sequences revealed a 
nucleotide sequence (PCV2/1) that inhibited the IFN-α production 
induced by stimulatory ODNs selected from the PCV2-genome and by 
some other well-known IFN inducers i.e. ADV, pcDNA3 and ODN 
2216, respectively  (Hasslung et al., 2003). Comparison of the 
sequence coding for ORF 2 of PCV2 in material obtained from pigs 
raised in healthy and diseased farms in Sweden have shown that the 
corresponding sequence appears in two different variants, here 
designated PCV2/1 and PCV2/1S1. PCV2/1 has only been found in 
samples from healthy pigs whereas PCV2/1S1 predominates in pigs 
from farms with PMWS.  
 
The present study was undertaken to further test the importance of CpG 
motifs, and formation of secondary structure for the IFN-α inducing 
capacity of short DNA sequences using poBMC. Further, the effect of 
natural occurring alterations in the regions of the PCV2 genome 
containing the IFN-inhibitory sequence was tested in vitro. 
 
 
Materials and methods 
Purification of poPBMC and induction of IFN-α 
Conventionally reared pigs housed at the Research Station Funbo, 
Lövsta, Uppsala, Sweden and specific pathogen free (SPF) pigs housed 
at Hagalund, Sala, Sweden were used. Serum samples from all pigs 
were tested and found negative for presence of IFN-α. Peripheral blood 
mononuclear cells (PBMC) were purified from heparinized blood by 
Ficoll-Paque (Amersham Biosciences AB, Uppsala, Sweden) density 
gradient centrifugation. The PBMC were suspended in growth medium 
i.e. RPMI 1640 medium (Biowhitaker, Verviers, Belgium) with 20 mM 
HEPES buffer, supplemented with L-glutamine (2 mM), penicillin (200 
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U/ml), streptomycin (100 µg/ml), 2-mercaptoethanol (5x10-5M ),  with 
10% foetal calf serum (FCS, Myoclone,  Invitrogen Life 
Technologies). The cells were seeded in flat-bottomed 96 well plates 
(F96 Cert, Nunc, Roskilde, Denmark) or in tissue culture flasks 
(NunclonTMSureface, Nunc, Roskilde, Denmark). For induction of IFN-
α production various ODNs as specified below were added in triplicate 
cultures with 5x106 poPBMC per ml in a total volume of 0.2 ml. After 
20h incubation at 37oC, 7% CO2 in air, culture supernatants were 
pooled and stored at -20oC until further analysis. As a control, 
lipofected plasmid DNA (pcDNA3; Invitrogen, San Diego, CA) was 
used at a final concentration of 2.5 µg per ml. 
 
ODNs 
Ten oligodeoxynucleotides (ODNs) were purchased from Cybergene 
AB (Stockholm, Sweden), desalted and dissolved in water. The ODNs 
were synthesised in various scales and delivered at stock concentrations 
given in Table 1. The nucleotide sequences of the ODNs are given in 
Table 1 and their theoretical ability to form double strands (IDT 
Scitools, Oligo Analyzer 3.0) is depicted in Figure 1.  
 
Table 1. Sequence of ODNs used for inhibition/induction of IFN-α in poPBMC and 
stock concentration for each ODN 
 Stock Final   
 conc.  conc. 
ODN           Sequence (5´→ 3´)a (µg/ml)b (µg/ml)c 
 
PCV2/1 CCC CCC TCC CGG GGG AAC AA 2430;2171;1907   25 
PCV2/1S GCC CCC TCC GGG GGG AAG AA 2148 25 
PCV2/1S1 GCC CCC TCC TGG GGG AAG AA 2422 25  
 
HB1G5’ GGG GGG TAT TTC GAA ATA GG 2574 25 
HB1G3’ GGT ATT TCG AAA TAG GGG GG 2716;640;634 25  
HB1G5’3’ GGG GGG TAT TTC GAA ATA GGG GGG 1980 25 
HB4G5’ GGG GGG TTC GAA GG 2960 25 
HB4G3’ GGT TCG AAG GGG GG 3039 25  
HB4G5’3’ GGG GGG TTC GAA GGG GGG 2317 25 
 
2216 ggG GGA CGA TCG TCg ggg gG 4171; 3268 5 
 
a All ODNs are built up by a phosphodiester backbone except from the chimeric ODN 
2216 which has phosphorotioate backbone at nucleotides in lower case. Underlined 
sequences correspond to CpG-motifs. b Stock concentration, the concentration that the 
ODNs was delivered at. Several different stocks of ODNs PCV2/1, HB1G3’ and 2216 
were used. c Final concentration used per ml culture medium 
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When indicated, one of the ODNs (2216) was diluted to a final 
concentration of 5 µg per ml growth medium and denatured by heating 
to approximately 100 oC for 5 min in a heating block followed by rapid 
cooling of the sample on ice water. Denaturation was estimated by 
measurement of the A260 values by spectrofotometric analysis 
(Nanodrop ND-1000 Spectrophotometer) prior to and after heat 
treatment of the ODN. All ODNs were tested for presence of endotoxin 
using the Limulus Amebocyte Lysate (LAL) QCL-1000 test kit 
(Cambrex Bio Science Walkersville, Inc, Walkersville) and were found 
to contain less than 0.2 EU per ml. 
 
 
HB1G5’        
dG: -19.41 kcal/mole 
 
5'-GGGGGGTATTTCGAAATAGG-3'  
         |||||||||||| 
    3'-GGATAAAGCTTTATGGGGGG-5' 
 
HB1G3’            
dG: -19.41 kcal/mole 
 
    5'-GGTATTTCGAAATAGGGGGG-3'  
         |||||||||||| 
3'-GGGGGGATAAAGCTTTATGG-5' 
 
HB1G5’3’            
dG: -19.41 kcal/mole 
 
5'-GGGGGGTATTTCGAAATAGGGGGG-3'  
         |||||||||||| 
3'-GGGGGGATAAAGCTTTATGGGGGG-5' 
 
HB4G5’  
dG: -10,65 kcal/mole 
 
5'-GGGGGGTTCGAAGG-3'  
         |||||| 
    3'-GGAAGCTTGGGGGG-5' 
 
HB4G3’ 
dG: -10,65 kcal/mole 
 
    5' GGTTCGAAGGGGGG 3' 
         |||||| 
3' GGGGGGAAGCTTGG 5' 
 
HB4G5’3’ 
dG: -10,65 kcal/mole 
 
5'-GGGGGGTTCGAAGGGGGG-3' 
         |||||| 
3'-GGGGGGAAGCTTGGGGGG-5' 
 
2216  
dG: -17.68 kcal/mole 
 
  5'-ggGGGACGATCGTCgggggG-3' 
         |||||||||| 
3'-GgggggCTGCTAGCAGGGgg-5' 
 
 
Figure 1. Predicted self-dimer structures of ODNs HB1G5’, HB1G3’, HB1G5’3’, 
HB4G5’, HB4G3’, HB4G5’3’ and 2216, showing the self-dimer formation with the 
lowest dG value. The predicted secondary structures were determined using the IDT 
SciTools Oligo Analyzer 3.0 software (http://www.idtdna.com/SciTools.sapx). 
 
Pre-incubation with Lipofectin® 
The effect of pre-treatment of the ODNs with Lipofectin® was tested as 
previously described (Magnusson et al., 2001a). In brief, the inducers 
were diluted in growth medium and when indicated incubated with 
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Lipofectin® (Lipofectin® Reagent, Invitrogen Life Technologies, 
Carlsbad, CA) for 15min before addition of PBMC to the wells. When 
PBMC were co-cultured with two inducers these were incubated with 
Lipofectin® together before addition of cells to the cultures. When 
present, the final concentration of Lipofectin® was in all cases 2.5 µg 
per ml.  
 
Detection of poIFN-α 
For quantification of INF-α a dissociation-enchanced lanthanide 
fluoroimmunoassay (DELFIA), which is based on two mAbs (F17 and 
K9-Eu) directed to poIFN-α (Artursson et al., 1995) was used. The 
IFN-α concentration was determined by comparison with a laboratory 
standard consisting of natural poINF-α. Results from the experiments 
are given as percentage of IFN-α induction by ODN 2216 or lipofected 
pcDNA3.    
 
Isolation of RNA and cytokine PCR 
To study the expression of cytokines genes, RNA was isolated from 
cells by Trizol extraction following the manual from the manufacturer 
(Invitrogen, Carlsbad, CA, USA). The sample RNA was resuspended in 
25µl diethylpyrocarbonate treated water (DEPC H20) and the quantity 
and purity (OD ratio 260/280 nm) of RNA were determined by 
spectrophotometric analysis (NanoDrop® ND-1000 Spectro-
photometer). Quality of the RNA was tested by agarose gel 
electrophoresis on a 1% TAE-agarose gel before using the RNA for 
cDNA production.  
 
Complementary DNA (cDNA) was produced from the sample RNA by 
Reverse Transcriptase PCR (RT-PCR) according to the protocol from 
Invitrogen (Stockholm, Sweden) with minor modifications. In short, 1 
µg of sample RNA was mixed with 4µl 10mM deoxynucleotide 
triphosphate-mix (dNTP)(TaKaRa Bio Inc., Shiga, Japan), DEPC H2O 
and 2µl of a specially designed oligo (dT) primer (530 µg/ml). The 
mixture was incubated at 65 oC for 5 min and cooled for 2 min at 1 oC. 
During cooling of the mixture a second mixture containing 8µl 5 x first 
strand buffer, 4µl 0.1 M DTT and 2µl RNAse Out (Invitrogen, 
Carlsbad, CA, USA) was added. After 2 min incubation at 42oC, to 
allow primer binding, Superscript II reverse transcriptase was added 
and the samples were incubated for 50 min at 42 oC. The enzymes were 
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deactivated by heating for 5 min at 75 oC and the samples were then 
quickly chilled to 4oC. To control for detection of genomic DNA in the 
analysis of IFN-α and IFN-β, which lack introns, a mixture without the 
Superscript II reverse transcriptase was run in parallel to those with the 
enzyme included. All the products were stored at -20 oC until further 
use. 
 
PCR amplifications of expressed cytokine genes were performed with 
primers designed using published porcine nucleic acid sequences 
selected from GenBank (Table 2). To minimise the risk of amplifying 
genomic DNA, the primers (Technology A/S, Aarhus, Denmark) were 
chosen to be located on different exons of the gene, with the exceptions 
of IFN-α and IFN-β, which lacks introns (Andersson M. et al., 2006, 
Wattrang E. et al., 2005, Zhu Z. et al., 2006). PCR products were 
synthesized for the following cytokines: IL-1β, IL-6, IL-8, IL-10, IL-12 
p35, IL-12 p40, IL-18, IFN-α, IFN-β, IFN-γ, TNF-α, TGF-β, MIF and 
GM-CSF. GAPDH and HPRT were used as housekeeping genes. The 
amplification of cDNAs was performed in two steps for the cytokines 
IFN-α, IFN-β, TNF-α and in one step for the rest of the cytokines and 
for the two housekeeping genes. The PCR amplification with two steps 
was in the case with IFN-α and IFN-β carried out using a specific 
forward primer (No. 3) and a common back primer (p23A) while in the 
case of TNF-α specific forward (Fw1) and specific backward (Bw1) 
primers were used.  In the second step primers 1 and 2 were used 
together at a concentration of 10 pmol/µl. The samples were heated to 
95 oC followed by a cycle consisting of denaturation for 30 s at 95 oC, 
annealing for 30 s and extension for 30 s at 72 oC with a final extension 
for 5 min at 72 oC. Annealing temperature and number of cycles used 
in the different amplifications are given in Table 3. The PCR products 
were analysed by agarose gel electrophoresis on a 1% TAE-agarose 
gel. 
 
 
 
 
 
 
 
 
 
 
 
 12 
Table 2. Oligodeoxynucleotide primers used to amplify porcine cytokine and house 
keeping genes. Primers designated 1 and 2 were used in the single step PCR 
amplification as well as in the second step of the two step PCR amplification. In the 
multi-PCR primers designated 3 and p23A were used for amplification of IFN-α and 
IFN-β and primers designated Fw1 and Bw1 were used for amplification of TNF-α 
 
Gene  
PCR pro-
duct (bp) 
 
Oligonucleotide sequences (5’-3’) 
GenBank 
acces. no. 
IL-1β1 378 (1) TGG ACC TTG GTT CTC TGA GA 
(2) CAT CTC CTT GCA CAA AGC TC 
M86725 
IL-41 296 (1) TGA ACA TTC TCA CAG CGA GA 
(2) TCA GCT TCA ACA CTT TGA GT 
L12991 
IL-61 666 (1) ATG AAC TCC CTC TCC ACA AG 
(2) CTA CAT TAT CCG AAT GGC CC 
M80258 
IL-81 304 (1) GAC TTC CAA ACT GGC TGT TG 
(2) GCT GTT GTT GTT GCT TCT CA 
AB057440 
IL-101 345 (1) GGC CCA GTG AAG AGT TTC TT 
(2) GAT GTC AAA CTC ACC CAT GG 
L20001 
IL-12 
p351 
502 (1) CGT CAG CAA CAC ACT TCA GA 
(2) GCT CAT CAT TCT GTC GAT GG 
L35765 
IL-12p 
401 
529 (1) TCC TGG TTT TCC CTG GTT TG 
(2) ACT TCT TAT ACT CCC CGA GG 
U08317 
IL-181 323 (1) ACT TTG GCA AGC TTG AAC CT 
(2) TCC AGG AAC ACT TCT CTG AA 
U68701 
IFN-α1 303 (1) CAG GAA GAA GGA GTG ACA GA 
(2) TAG GCA GCA AGG GCA TCT AT 
(3) CAG AAA CCT GCA AGA CAG AC 
M28623 
IFN-β1 291 (1) TGG ATG ACC TGG AGA CAA TC 
(2) AAA GAG CTT CCC CTG CTT GA 
(3) CTT GTG GAA CTT GAT GGG CA 
M86762 
IFN-γ1 392 (1) GAC ATG TTT CAG AGG TTC CT 
(2) AGT CAC AGG ATA CAG GAA TC 
AY188090 
TNF-α2 286 
 
156 
(Fw1) ACT GAG AGC ATG ATC CGA GA 
(Bw1) CGG CTT TGA CAT TGG CTA CA 
(1) GTG CCT CAG CCT CTT CTC CT 
(2) GTT TGA GAC GAT GAT CTG AG 
X57321 
TGF-β4 399 (1) GAG CCA GGA CCT TGC TGT AC  
(2) GAC CCG CAG AGA GGC TAT AG  
Y00111  
MIF1 251 (1) TGG   TGC AGG CCA TGG GC A AG 
(2) GTT CCA GCC CAC ATT GGC CG 
AF176246 
GM-CSF1 301 (1) CAA GCA CTA TGA GCA GCA CT 
(2) GCC TGT ATC AGG GTC AAC AT 
AY116504 
GAPDH1 520 (1) ATG GTG AAG GTC GGA GTG AA 
(2) TCA TGA GTC CTT CCA CGA TG 
AF017079 
HPRT1 365 (1) TGC CGA GGA TTT GGA AAA GG 
(2) CCA AGG AAA GCA AGG TTT GC 
AF143818 
cDNA-
primer3 
 CCT GAC CCA ACC AGT AGA CCA TTT 
TTT TTT TTT TTT TTT TN 
 
p23A  TGA CCC AAC CAG TAG ACC A (Berg et al., 1999) 
1 From Andersson et al., 2006, 2 From Zhu et al., 2006,3 Verfaillie et al., 2005, 4 From 
Wattrang et al., 2005 
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Table 3. Annealing temperature and number of cycles used in the PCR reactions 
 Nested PCR Multi PCR 
 
Cytokine 
Annealing 
temperature (oC) 
No. of  
cycles 
Annealing 
temperature (oC) 
No. of  
cycles 
IL-1β 58 30   
IL-4 55 30   
IL-6 55 25   
IL-8 60 26   
IL-10 60 30   
IL-12 p35 55 35   
IL-12 p40 60 35   
IL-18 58 35   
IFN-α 60 20 55 35 
IFN-β 60 20 60 35 
IFN-γ 55 35   
TNF-α 60 20 60 30 
TGF-β 60 35   
MIF 65 35   
GM-CSF 55 30   
GAPDH 55 30   
HPRT 55 30   
 
Data and statistical analysis 
All data are expressed as mean values ± SEM. Statistically significant 
differences, in IFN-α induction (units per ml) by various ODNs were 
determined using the Wilcoxon rank-sum test (Stat view 512, version 
1.01, Abacus Concepts, Calabas, USA). A value of p ≤ 0.05 was 
considered as significant. 
 
 
Results 
IFN-α production induced by various phosphodiester ODNs 
To test the effect of poly-G-sequences at the 5’ and/or 3’ ends of ODNs 
with various lengths of base-pairing sequences (6nt or 12 nt), six 
different ODNs with the same central hexamer (5’-TTCGAA-3’), 
HB1G5’, HB1G3’, HB1G5’3’, HB4G5’, HB4G3’, HB4G5’3’ were 
tested for their ability to induce IFN-α production by poPBMC. All six 
ODNs were able to induce IFN-α production after pre-incubation with 
Lipofectin® but at various levels. Three ODNs (ODN HB1G5’, ODN 
HB1G3’ and ODN HB4G3’) consistently induced higher levels of IFN-
α (621±399, 695±457, 744±432 units per ml respectively; 
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meanvalue±SEM, n=6), than the other three ODNs (189±195, 46±63 
and 209±299 units per ml; mean value±SEM, n=6), but in all cases the 
magnitude of responses varied considerably between pigs. To adjust for 
this individual variation in IFN-α producing capacity (Edfors-Lilja et 
al., 1998), the plasmid pcDNA3 was included at all test occasions, and 
the levels of IFN-α induced by an ODN was expressed as percentage of 
the corresponding value induced by pcDNA3. This comparison 
revealed that three of the ODNs induced as much, or even more, IFN-α 
than plasmid DNA3 when pre-incubated with Lipofectin® (Fig. 2). 
Only one of the ODNs (HB1G5’), induced IFN-α without pre-
incubation with Lipofectin® and these levels were consistently lower 
than those induced in the presence of Lipofectin®. ODNs HB4G3’ and 
HB4G5’3’ were only able to induce trace amounts of IFN-α 
(corresponding to 0.2% and 3.0% of the amounts induced by pcDNA3 
respectively) when not pre-incubated with Lipofectin®. 
 
30
3
12
46
163
145
174
45
0 20 40 60 80 100 120 140 160 180 200
HB1G5'
HB1G3'
HB1G5'3'
HB4G5'
HB4G3'
HB4G5'3'
IFN-alpha % of lipofected pcDNA3
 
Figure 2. The IFN-α inducing capacity of the ODNs HB1G3’, HB1G5’, HB1G5’3’, 
HB4G5’3’, HB4G3’, HB4G5’, used at a concentration of 25µg/ml. The results are 
given as mean values ± SEM, n=6, expressed as percentage of the IFN-α levels 
(U/ml) induced by lipofected pcDNA3. The IFN-α production induced by pcDNA3 
varied between 188-723 units IFN-α per ml for the experimental pigs. Open bars 
correspond to cultures induced with ODNs in the absence of Lipofectin®, and filled 
bars to cultures where ODNs were pre-treated with Lipofectin®. 
 
Thus, addition of a poly-G sequence to the 3´end enhanced the IFN-α 
inducing capacity of the ODN, irrespectively of the length of the 
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central base-pairing sequence. Addition of a poly-G sequence to the 5’ 
end also enhanced the IFN-α inducing capacity of the longer ODN but 
had no enhancing effect on the ODN with a short (6nt) base-pairing 
sequence. Addition of a poly-G sequence to both 5’ and 3’ ends 
reduced the IFN-α inducing capacity of both the 6nt and 12nt long 
basepairing ODNs 
 
IFN-α production induced by ODN HB1G3’ synthesised at 
different stock concentrations 
The fact that HB1G3’ was unable to induce IFN-α production without 
pre-incubation with Lipofectin® was contradictory to previous results 
using a lower stock concentration (approximately 250-640 µg per ml) 
of the ODN  (Hasslung et al., 2006). Therefore two different stock 
solutions (concentrations approximately 600 and 2700 µg per ml 
respectively) of ODN HB1G3’ were tested for their IFN-α inducing 
capacity, both at a final concentration of 25µg per ml culture medium. 
Results from this comparison are summarised in Figure 3 and show that 
ODN prepared from the lower stock concentration induced higher 
levels of IFN-α than ODN kept at a higher stock concentration. This 
difference was most clearcut when the ODN was used in the absence of 
Lipofectin®. When not lipofected, IFN-α level of 41±100 units per ml 
was induced by ODN HB1G3’ at the stock concentration of 2716 µg 
per ml, which corresponds to 4% of the IFN-α induction obtained with 
lipofected pcDNA3. HB1G3’ at the stock concentration of 250-640 µg 
per ml not pre-incubated with Lipofectin® induced 1354±1317 units per 
ml, which equals 184% of the IFN-α induction obtained with lipofected 
pcDNA3. This difference in results by the various preparations of ODN 
indicates that the physical form of the ODN was altered when the ODN 
was kept at various stock concentrations in a way that affected its 
ability to induce IFN-α production. 
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Figure 3. Production of IFN-α by porcine peripheral blood mononuclear cells 
(PBMC) stimulated with ODN HB1G3’ (25 µg/ml), delivered at different stock 
concentrations (600 or 2700 µg per ml). Results are given as mean values ± SEM, 
n=17, expressed as percentage of IFN-α induced by lipofected pcDNA3 (996±566 
units IFN-α per ml). Open bars correspond to cultures induced with ODNs in the 
absence of Lipofectin® and filled bars to cultures were ODNs where pre-treated with 
Lipofectin®. 
 
IFN-α inducing capacity of denatured ODN 2216 
To study whether self-complementary single stranded ODNs 
spontaneously form double strands or other multimeric forms during 
storage, a well-known IFN-α inducing CpG-ODN, ODN 2216, was 
used. This ODN has a chimeric backbone with phosphodiesters and 
phosphorothioates, a polyG-tail at the 3’ end, and a theoretical capacity 
to form double strand allowing a 10 nucleotide long base-pairing 
sequence as depicted in Figure 1. 
 
ODN 2216 was used for in vitro IFN-α induction un-treated or after 
heat-treatment/denaturation for 5 min at 100oC. The denaturation was 
estimated by measurements of the A260 values, which increased with 
approximately 20% after heat treatment. Both preparations of ODN 
2216 were tested neat or pre-incubated with Lipofectin® and the 
response was compared to that induced by pcDNA3 in the same pig 
(Fig. 4).  
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Figure 4. Alterations in the IFN-α inducing capacity of ODN 2216 before and after 
heat treatment. The ODN was used at a concentration of 5µg/ml and the results are 
given as mean values ± SEM, n=16, expressed as percentage of the IFN-α induced by 
lipofected pcDNA3. Open bars correspond to cultures induced with ODNs in the 
absence of Lipofectin® and filled bars to cultures where ODNs were pre-treated with 
Lipofectin®. 
 
The heat treatment/denaturation of ODN 2216 reduced the IFN-α 
inducing capacity of the ODN from 151% (native) to 33% (heat-
treated) of the IFN-α production induced by pcDNA3. Interestingly, 
the IFN-α inducing capacity of ODN 2216 could be restored after 
denaturation through pre-incubation of the heat-treated preparation with 
Lipofectin® (1837±930 units per ml), which corresponds well to the 
levels of IFN-α induced by the native ODN 2216 pre-incubated with 
Lipofectin® (1701±868 units per ml). Thus, the IFN-induction by ODN 
2216 was clearly reduced by heat-treatment but the denatured 
preparation regained the IFN-α inducing capacity by pre-incubation 
with Lipofectin®. These results indicate that the IFN-α inducing 
capacity of the ODN is dependent on formation of multimeric 
structures. 
 
Effects of minor modifications in the sequence of ODN PCV2/1 on 
the inhibition of IFN-α production 
An ODN corresponding to a 20 nucleotide long sequence from the 
genome of PCV2 (Imp. 1010 Stoon) has previously been shown to 
inhibit the IFN-α production induced by some other ODNs including 
ODN 2216 (Hasslung et al., 2003). Preliminary data demonstrated that 
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this inhibitory effect was dependent on the secondary structure of the 
ODN PCV2/1 (Hasslung et al., 2006). To further study the influence of 
exchanging nucleotides within ODN PCV2/1 that not affected the 
hairpin formation but modified the CpG motif, two new variants of the 
ODN where synthesised, PCV2/1S and PCV2/1S1 (Fig. 5).  
 
 
   
a.    b.   c.  
Figure 5. Predicted hairpin formation of the ODNs PCV2/1, dG: -5.7 kcal/mol (a), 
PCV2/1S, dG: -6.3 kcal/mol (b) and PCV2/1S1, dG: -6.2 kcal/mol (c). The predicted 
secondary structures were determined using the IDT SciTools Oligo Analyzer 3.0 
software (http://www.idtdna.com/SciTools.sapx). 
 
When tested in cultures of poPBMC, none of the three ODNs (ODN 
PCV2/1, ODN PCV2/1S, ODN PCV2/1S1) were able to induce IFN-α 
production regardless of whether the ODNs were pre-incubated with 
Lipofectin® or not. The ability of the various PCV2-ODNs to inhibit 
IFN-α production induced by ODN 2216 was tested in cultures of 
poPBMC in the presence of ODN 2216 and one of the PCV2-ODNs. 
The IFN-α production induced by ODN 2216 without pre-incubation 
with Lipofectin® varied from 187 to 2084 U IFN-α/ml (950±806 units 
IFN-α per ml; mean value±SEM, n=6) but was decreased by all three 
ODNs tested (ODN PCV2/1: range <0 to 253; ODN PCV2/1S: range 
3.8 to 497; ODN PCV2/1S1: range 5.5 – 468 units IFN-α per ml). A 
similar variation between individuals was found with lipofected ODN 
2216 alone (from 334 to 1868 units IFN-α per ml; 1093±643 units IFN-
α per ml; mean value±SEM n=6) and in combination with lipofected 
ODN PCV2/1 (0.8 – 352 units IFN-α per ml), ODN PCV2/1S(16 – 718 
units IFN-α per ml) or ODN PCV2/1S1 (17 – 814 units IFN-α per ml) 
as shown in Figure 6. 
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Figure 6. Inhibitory effect of ODNs PCV2/1, PCV2/1S and PCV2/1S1 on the IFN-α 
production induced by ODN 2216. The IFN-α production is expressed as units per ml 
and the results are given as mean values ± SEM, n=6. Open bars correspond to 
cultures induced by ODNs in the absence of Lipofectin® and filled bars to cultures 
where ODNs were pre-treated with Lipofectin®. 
 
Statistical analysis showed that the concentration of IFN-α was 
significantly lower (p<0.05, Wilcoxon rank-sum test) in supernatants 
collected from cultures of poPBMC incubated with the combination of 
ODN PCV2/1 and ODN 2216 than in those incubated with the 
combination of ODN 2216 and ODN PCV2/1S or ODN PCV2/1S1, 
regardless of pre-incubation of the ODNs with Lipofectin® or not. 
Thus, the CpG-motif is not vital for the ODNs IFN-α inhibitory 
capacity since no significant difference could be seen between the 
inhibitory effect of ODN PCV2/1, containing a CpG-motif, and 
PCV2/1S1, lacking a CpG-motif. The inhibitory capacity of lipofected 
ODN PCV2/1S1 was consistently greater than that of ODN PCV2/1S1 
not pre-incubated with Lipofectin® (p< 0.03). 
 
To correct for the variation in IFN-α producing capacity between pigs 
the inhibitory effect was expressed as percentage of the amount IFN-α 
induced by ODN 2216. These results illustrated that the unmodified 
ODN PCV2/1 had the best inhibitory capacity compared to ODN 
PCV2/1S and ODN PCV2/1S1, both in the presence and absence of 
Lipofectin®. As can be seen in Figure 7, ODN PCV2/1 was able to 
inhibit 95% of the IFN-α production induced by ODN 2216 both when 
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pre-incubated with Lipofectin® and not, while neat ODN PCV2/1S and 
ODN PCV2/1S1 inhibited 87% and 90% of the IFN-α induced by 
ODN 2216 respectively. When lipofected, the inhibitory action of ODN 
PCV2/1S and ODN PCV2/1S1 on IFN-α induction obtained from 
ODN 2216 was slightly less than 80% and 77%, respectively. Analysis 
of the correlation between the concentration of IFN-α induced by ODN 
2216 and the inhibitory capacity of ODN PCV2/1 revealed that the two 
parameters were related to each other (r = -0.93, correlation coefficient) 
although in all cases the inhibitory capacity of ODN PCV2/1 was more 
than 75% (Fig. 8).  
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Figure 7. The effect of the ODNs PCV2/1, PCV2/1S and PCV2/1S1 on the IFN-α 
production induced by ODN 2216 at co-culture. The IFN-α production is expressed 
as percent inhibition in co-cultures compared to IFN-α production induced by ODN 
2216 alone, which varied between 187-2084 units per ml.  The results are given as 
mean values ± SEM, n=6. Open bars correspond to cultures induced with ODNs in 
the absence of Lipofectin® and filled bars to cultures where ODNs were pre-treated 
with Lipofectin®. 
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Figure 8. Correlation between the amount of IFN-α (U/ml) induced by ODN 2216 
and the inhibitory capacity of ODN PCV2/1 in percent (correlation coefficient =        
-0.93). 
 
Cytokine expression at mRNA-level in poPBMC cultured with 
ODNs 2216, PCV2/1 or in combination of the two ODNs  
It is unknown at which level ODN PCV2/1 inhibits the IFN-α 
induction of other CpG ODNs. To further elaborate the inhibitory 
function of ODN PCV2/1, the effect of ODN PCV2/1 on the expression 
of cytokines at messenger RNA-level was studied by RT-PCR. 
 
The mRNA expression of the cytokines, IL-1β, IL-6, IL-8, IL-10, IL-12 
p35, IL-12 p40, IL-18, IFN-α, IFN-β, IFN-γ, TNF-α, TGF-β, MIF and 
GM-CSF, was determined by PCR analysis of RNA isolated from 
poPBMC cultured in the presence of ODN 2216 or/and ODN PCV2/1 
or in plain growth medium. Parallel cultures were initiated and cells for 
mRNA analysis were collected after 6 hours whereas culture 
supernatants for detection of secreted IFN-α were collected after 24 
hours of incubation. The inductions were repeated with cells obtained 
from different pigs and in many cases mRNA for several of the 
cytokines were detected at PCR analysis of unstimulated PBMC. 
Therefore, it only became clear that transcription of for IFN-α and IFN-
β were induced in cultures with ODN 2216 alone or in the combination 
with ODN PCV2/1. As shown in Figure 9, the levels of IFN-α 
determined in culture supernatants after 24 hours were considerably 
reduced when the cells were cultured in a mixture of ODN 2216 and 
ODN PCV2/1 compared to when cultured with only ODN 2216. It is 
notable that in one case mRNA for IFN-α was detectable in a culture 
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with unstimulated cells, while this signal was absent in the culture with 
cells from the same pig induced with ODN PCV2/1, although it is still 
unknown how PCV2/1 inhibits the production of IFN-α. 
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Figure 9. The IFN-α induction in parallel cultures incubated at 37oC in the presence 
of ODN 2216 and/or ODN PCV2/1 or in plain growth medium. Products for mRNA 
analysis were run on 1% agarose gel (a) and as a control a mixture without the 
Superscript II reverse transcriptase (RT-) was run in parallel to those with the enzyme 
included (RT+) for IFN-α and IFN-β. Supernatants from the corresponding 24 hours 
cultures were collected and analysed for presence of secreted IFN-α (b). 
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Discussion 
In the present study, synthetic ODNs were tested for their ability to 
induce or inhibit IFN-α production by poPBMC in vitro. Studies of 
ODN H (5’-TTTTCAATTCGAAGATGAAT-3’), originally identified 
in serum from a patient with systemic lupus erythematosus (SLE), have 
shown that the ODN after pre-treatment with Lipofectin® is able to 
induce IFN-α in human (Magnusson et al., 2001b) and porcine 
(Domeika et al., 2004) PBMC. Further, in vitro studies have shown that 
the IFN-α inducing capacity of ODN H can be increased by double 
strand formation and/or addition of repeated guanosines (poly-G) 
sequences, although none of the modifications abolish the need for pre-
treatment with Lipofectin® (Domeika et al., 2004; Hasslung et al., 
2006), which also have been indicated for other phophodiester ODNs 
(Pisetsky, 1999a; Dalpke et al., 2002). To further study the importance 
of double strand formation and poly-G sequences six new variant of 
ODN H, designated ODN HB1G5’, HB1G3’, HB1G5’3’, HB4G5’, 
HB4G3’ and HB4G5’3’, were constructed and tested for their IFN-α 
inducing capacity in porcine PBMC. All six of the ODNs contained the 
central hexamer motif present in ODN H (5’-TTCGAA-3’) and in 
addition to this the total number of possible base pairs in a self-dimer 
structure was varied as well as the position of the poly-G sequences. 
 
According to the present study neither addition of a poly-G sequence at 
the 5’ or the 3’ end of the ODNs nor increasing the total number of 
possible base pairs in a self-dimer structure circumvented the need for 
pre-treatment with Lipofectin® in order to induce IFN-α production. 
After pre-treatment with Lipofectin® three out of the six ODNs ODN 
HB1G5’, ODN HB1G3’ and ODN HB4G3’ readily induced IFN-α, 
while HB1G5’3’, HB4G5’ and HB4G5’3’ only were able to induce 
small amounts of IFN-α. This suggest that for the ODNs with a 
basepairing sequence of 12 nucleotide an addition of poly-G sequence 
at either the 5’ or 3’ end can enhance its IFN-α inducing capacity, 
while addition of poly-G sequences at both 5’ and 3’ ends decreased 
the amount of IFN-α induced.  Although when the base pairing 
sequence was shorter, 6 nucleotides, addition of a poly-G sequence at 
the 3’ end is the only modification that enhanced the IFN-α inducing 
capacity. The importance of an addition of a poly-G sequence to the 3’ 
end of the ODN was in common for ODNs with both 12 and 6 nt base-
pairing sequences. This enhancing effect could be explained by 
protection of the 3’ end of the ODN from 3’ exonuclease activity in cell 
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cultures (Clusel et al., 1993). Furthermore, the increase in IFN-α 
production could be ascribed to the possible spontaneous formation of 
nanoparticels since ODNs with at least four guanosines in their poly-G 
sequences are known to self-associate via Hoogsteen base pairing to 
form quadruplex structures i.e. G-tetrads (Williamson et al., 1989) 
which has been suggested to enhance cellular uptake via scavenger 
receptors and thereby contribute to the immune modulatory activity of 
the ODNs (Dalpke et al., 2002). On the other hand, addition of a poly-
G sequence at the 5´ end of the ODN has been suggested to be 
unfavourable since the cellular recognition of the nucleotide sequence 
is performed in a 5’ – 3’ direction (Yamada et al., 2002; Kandimalla et 
al., 2002). Nevertheless, addition of a poly-G sequence at the 5’ end of 
the HB1G5’ enhanced the IFN-α inducing capacity of this particular 
ODN. 
 
Unexpected results have been described previously when testing 
various ODNs for biological effects. Indeed, the same ODN sequence 
synthesized by various companies gave diverging results when tested 
with poPBMC (Van der Stede et al., 2005). The ODNs used in the 
present study have each time been ordered desalted and dissolved in 
water from the same company. Despite that when compared to results 
from previous studies of ODN HB1G3’ (Hasslung et al., 2006) a 
remarkable difference was found. In the present study, ODN HB1G3’ 
seem to be dependent on pre-treatment with Lipofectin® to be able to 
induce IFN-α production in poPBMC while the previous studies have 
shown that addition of a poly-G sequence to the 3’ end of the ODN H 
eliminated the need for Lipofectin® pre-treatment. These discrepancies 
lead us to believe that the properties of the ODN were influenced by the 
stock concentration in which the ODN was delivered. Comparison 
between results from tests performed with ODN HB1G3’ delivered at 
different stock concentrations further supported this assumption as 
ODNs from the lower stock concentration (600 µg/ml) seemed to have 
a better IFN-α inducing capacity also in the absence of Lipofectin®. 
Theoretically, ODN H can form nanoparticle structures similar to what 
has been described for ODN 2216 (Kerkmann et al., 2005).  
 
To test the importance of base-pairing between ODNs secondary 
structures of ODN 2216 were denatured by heat treatment i.e. heating 
to approximately 100oC and rapid cooling. This treatment reduced the 
IFN-α inducing capacity from ODN 2216, but this could be restored by 
treatment of the denatured ODN 2216 with Lipofectin®. Thus, the 
incorporation of an ODN into a larger structure which is provided by 
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cationic lipids mimicking the spontaneously assembled nanoparticles 
present among untreated ODN 2216 seems to be important for it’s 
ability to induce IFN-α production. The importance of ODN 
aggregation might also explain the differences in results obtained using 
preparations of ODN HB1G3’ delivered at various stock concentrations 
because it has been shown that ODNs at a high concentration form a 
complex network of unspecific DNA structure rather then assembled 
nanoparticles (Costa et al., 2004). Thus, addition of poly-Guanosine 
sequences (poly-G sequences) to the ODNs can affect their 
immunostimulatory activity most likely due to formation of secondary 
structures. The formation of secondary structures appear to facilitate 
the uptake/internalisation of CpG DNA in the cells and thereby 
increase the IFN-α inducing capacity of the ODN (Kandimalla et al., 
2003; Domeika et al., 2004). 
 
ODNs have not only been described as potent IFN-α inducers, but 
certain ODNs instead act inhibitory on the IFN-α production induced 
by other ODNs, viral inducers or bacterial inducers. The genome of 
PCV2 has been shown to contain several nucleotide sequences with the 
ability to modulate the porcine immune response among them an 
inhibitory sequence, PCV2/1 (Hasslung et al., 2003). In the present 
study three variants of the inhibitory sequence PCV2/1 were shown to 
inhibit the IFN-α production by ODN 2216 to a variable degree. The 
first variant, ODN PCV2/1, has only been found in samples from 
healthy pigs in Sweden while the second variant of the ODN, ODN 
PCV2/1S1, predominates in pigs from Swedish farms with PMWS. To 
study the significance of the central CpG-motif in the sequence a third 
ODN, with a nucleotide-exchange in the CpG-motif, was constructed, 
PCV2/1S. All three variants were used to measure their ability to 
inhibit IFN-α production by ODN 2216. The result presented 
demonstrate that the inhibitory capacity of ODN PCV2/1 was retained 
although minor modifications to the nucleotide sequence of the ODN 
were performed. Nevertheless, these modifications did result in a 
difference (p<0.03) in the degree of inhibition of the IFN-α production 
by poPBMC. In accordance with previous studies using neutralizing 
phosphorothioate ODNs (Zhao et al., 2000) this study clearly 
demonstrate that the inhibitory capacity of the ODN PCV2/1 is not 
dependent on the presence of a central CpG-motif since no significant 
difference between the inhibition obtained from the ODN PCV2/1S1, 
lacking a CpG-motif, and PCV2/1S, with an introduced CpG-motif, 
were found. 
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Theoretically the nucleotide sequence of ODN PCV2/1 gives it the 
possibility to spontaneously form secondary hairpin structures, as 
depicted in Figure 6, which has been shown to be crucial to the 
inhibitory action of the ODN (Hasslung et al., 2006). This might in fact 
be a way for the ODN to act in an inhibitory way on the IFN-α 
production induced by TLR9 agonists. Secondary structures such as 
hairpins in DNA can bind to transcription factors (Chu et al., 1991) and 
they also provide a protection, which make them more resistant against 
degradation by endonucleases than ss DNA (Chu et al., 1992), and this 
could prolong the inhibitory activity of ODN PCV2/1. In addition, the 
formation of higher-order structures might explain why the inhibition 
not was totally dependent on pre-treatment with Lipofectin®. 
 
To study if ODN PCV2/1 inhibited IFN-α production before or after 
transcription of the gene the mRNA was determined for a number of 
cytokines. Even though the parallel inductions for 6 and 24 hours were 
repeated several times with cells obtained from different pigs no 
conclusive results were obtained. In most cases cytokine mRNA was 
detected in samples collected from PBMC grown in plain medium. 
Nevertheless it is clear that transcription of IFN-α and IFN-β were 
induced in cultures with either ODN 2216 alone or in combination with 
ODN PCV2/1. Analyses of supernatants collected from the 24 hours 
incubations showed a considerably reduction of secreted IFN-α in co-
cultures with ODN 2216 and ODN PCV2/1 compared to cultures with 
only ODN 2216. In other systems, competition between inhibitory and 
stimulatory ODNs has been suggested and one theory is that binding of 
inhibitory ODNs to TLR9 results in a conformational change of the 
MyD88 binding site which interrupts the further signalling through 
TLR9 (Ashman et al., 2005; Lenert et al., 2006), which would mean 
that the inhibitory effect of the ODN is exerted before transcription of 
the mRNA. In the present study, the method used for detection of 
cytokine mRNA was not quantitative and therefore the amount of 
transcribed IFN-α and IFN-β in co-cultures with ODN 2216 and ODN 
PCV2/1 could not be compared to the amounts in cultures with only 
ODN 2216. Thus, additional studies using a quantitative method is 
needed to elaborate the mechanism behind the IFN-α inhibitory 
capacity of the ODN PCV2/1. Further, results from the in vitro studies 
show a significant difference between ODN PCV2/1 found in the 
genome of PCV2 from healthy pigs in Sweden and ODN PCV2/1S1, 
which predominates in pigs from farms with PMWS in Sweden. 
However, the biological significance of these findings remain to be 
elucidated. 
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